FIELD: medicine. SUBSTANCE: the products: N-substituted derivatives of (3R, 4R)-3-ethyl-4-[(1-methyl-1H-imidazol-5-yl)methyl]-2-pyrrolidone of the formula 1 reported in the specification wherein R is R-(C1-C20)-alkyl, optionally substituted for a trimethylsilyl group, hydroxy, acetoxy or an isopropoxycarbonyl group, norbornyl, (C1-C4)-alkylbenzyl or 3,4-dimethoxybenzyl group or their pharmaceutically acceptable acid addition salts having antiglaucomic activity. Reagent 1: (3R,4R)-3-methyl-4-[(1-methyl-1H-imidazol-5-yl)methyl] -2-pyrrolidone. Reagent 2: an acylating agent: halogen or cyanoformate of the formula: XCO2R or an anhydride of the formula: n1O2COCO2n wherein R is as defined above; X is halogen or a cyano group; R1 is a hydrocarbon group, or p-nitrophenylcarbonate of the formula: O2N=(C6-H4)-COOR wherein R is as defined above. EFFECT: improved properties of the N-substituted derivatives. 6 dwg, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD OF SYNTHESIS OF STEREOSPECIFIC COMPOUND | 1989 |
|
RU2024528C1 |
PROCESS FOR PREPARING ACETYLENE DERIVATIVES OF CHROMAN OF THIOCHROMAN | 1990 |
|
RU2015969C1 |
NUCLEOSIDE PHOSPHORYLASES AND NUCLEOSIDASES INHIBITORS | 2003 |
|
RU2330042C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTION OR TREATMENT MACULAR DEGENERATION | 2012 |
|
RU2576380C2 |
SUBSTITUTED CYCLOPENTANES, POSSESSING PROSTAGLANDIN ACTIVITY | 2009 |
|
RU2505530C2 |
SUBSTITUTED 3-AMINOQUINUCLIDINES | 1992 |
|
RU2092486C1 |
METHOD FOR PREPARING SUBSTITUTED O-ALKYLATED HEXAHYDRO-2H-CHROMENO[4,3-D]PYRIMIDINE-2,5(1H)-DIONES | 2022 |
|
RU2796532C1 |
METHOD OF SYNTHESIS OF BENZOXAZOLONE DERIVATIVES | 1990 |
|
RU2036913C1 |
C-2'-METHYLATED DERIVATIVES OF PACLITAXEL FOR USING AS ANTITUMOR AGENTS | 2002 |
|
RU2287528C2 |
DERIVATIVES OF SUBSTITUTED PYRROLOPYRIDINONE USEFUL AS PHOSPHODIESTERASE INHIBITORS | 2001 |
|
RU2267490C2 |
Authors
Dates
1994-07-15—Published
1990-11-12—Filed